The IRA Playbook for Current & Future Negotiators
Leveraging the Lessons Learned for June 2025 and beyond
Join our experts with direct involvement in both rounds of the Medicare Drug Price Negotiation Program. Listen to real talk on the tactics for June 2025 and strategic advice for manufacturers looking beyond IPAY2027. Our advisors will bring front-line insight and critical thinking from the worlds of negotiation strategy, CMS legal and regulatory affairs, health technology assessment, and human performance factors.
Core themes to be covered:
How CMS’s playbook is shifting for IPAY 2027 compared to IPAY 2026
How to sharpen your negotiation strategy if you're currently involved in IPAY 2027
What’s coming for IPAY 2028 and beyond
How to get ahead if you’re expecting to enter future IRA negotiations
By joining, you’ll walk away with:
Key tips on setting your brand up for negotiation success
Ways to save time and organizational resources during preparation
Strategies to negotiate more effectively
Insights into preparing for potential Part B inclusion
Direct access to advisors who have navigated past and current negotiations first-hand
Join us live Wednesday 14 May, 2025
0800 PDT / 1100 EDT / 1600 London
REGISTER NOW
Format & Duration
45-minute fireside chat with a panel of professionals involved in previous and current IRA negotiations, followed by 15-minutes audience Q&A.
Who Should Attend?
This webinar is open exclusively to personnel from pharmaceutical manufacturers in the following functions will benefit from attending the webinar:
| Brand | Contract Operations | Contract Strategy |
| Corporate Communications | Government Affairs | Finance |
| Leadership | Legal | Managed Markets |
| Market Access | Pricing Operations | Real-world Evidence |
| Government Pricing | Marketing | Key Accounts |
Join us live Wednesday 14 May, 2025
0800 PDT / 1100 EDT / 1600 London
REGISTER NOW
Speakers
Nick Merryfield
CEO, Verpora
& Webinar Chair
Nick is a pioneer in the field of applying the aviation-based science of Human Factors to pharmaceutical negotiations and organizational efficiency.
LinkedIn
Chris Webber
Head of Negotiation, Verpora
20+ years advising pharmaceutical manufacturer negotiations with governments, health insurers, and PBMs both in the U.S. and globally.
LinkedIn
Omar Ali
Head of Payers, Verpora
Former Health Technology Assessment advisor to NICE with 25+ years experience supporting manufacturers in government and commercial negotiations both in the U.S. and globally.
LinkedIn
Erin Estey Hertzog
Partner, Manatt Health
Over 15 years of experience as a healthcare regulatory attorney, including extensive experience advising manufacturers on their engagements with CMS.
LinkedIn
Ross Margulies
Partner, Manatt Health
Over 15 years of experience as a healthcare regulatory attorney, including extensive experience advising manufacturers on their engagements with CMS.
LinkedIn
Join us live Wednesday 14 May, 2025
0800 PDT / 1100 EDT / 1600 London
REGISTER NOW
About Verpora
Verpora is a highly specialized consultancy in the field of innovative contracting and value-based pricing for the life sciences industry.
In a novel, first-of-its-kind approach, Verpora has pioneered the integration of human performance factors with payer behavior, data science and commercial negotiation strategy to deliver outcomes that are outstanding.
When healthcare innovations struggle to demonstrate their true value to stakeholders, Verpora’s team of experts leverage the relationship between people, data, and the systems in which they interact to optimize patient access and price for healthcare technologies.
About Manatt
Manatt is a multidisciplinary, integrated national professional services firm known for quality and an extraordinary commitment to clients. We are keenly focused on specific industry sectors, providing legal and consulting capabilities at the very highest levels to achieve our clients’ business objectives.
Our groundbreaking approach—bringing together legal services, advocacy and business strategy—differentiates us from our competitors and positions us to provide a unique and compelling value proposition. We strive to be essential to our clients.